Here, we also show that expression of CLDN9 is significantly correlated with ZO-1 and ZO-3 and the integrated co-expression of CLDN-9, ZO-1 and ZO-3 markedly improve the prognostic value in breast cancer. This evidence concerns the gene TJP3 and breast carcinoma.